Association of prescribed oral stimulants on cocaine use among patients enrolled in opioid agonist treatment
A retrospective longitudinal cohort study
Bibliographic Data
| ID | 15516420 |
|---|---|
| Authors | Mark Tatangelo (0000-0003-0391-2497, NOSM University), Farah Tahsin (0000-0001-9077-7670, Public Health Ontario), Kristen A Morin (0009-0001-4059-3475, Health Sciences North), David C Marsh (0000-0002-8769-1785, Institute for Clinical Evaluative Sciences, corresponding author) |
| Year | 2022 |
| Volume | 13 |
| Pages | 1074691-1074691 |
| Publication date | 2022-12-02 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.1074691 |
| PMID | 36532164 |
| OpenAlex | W4311104067 |
| Language | EN |
| References cited | 21 |
The use of oral stimulant prescriptions to treat cocaine use had no clinically significant benefit in a real-world setting. Patients who receive prescriptions for oral stimulants consume more cocaine before and after treatment compared to patients without an oral stimulant prescription. We also observed that cocaine use was reduced with increased time since treatment initiation
Agonist · Anesthesia · Cohort · Opioid · Psychiatry · Receptor · Retrospective cohort study · Attention Deficit Hyperactivity Disorder · Forensic Toxicology and Drug Analysis · Medicine · Opioid Use Disorder Treatment · Internal Medicine
Diagnostic and Statistical Manual of Mental Disorders
An overview of systematic reviews of the effectiveness of opiate maintenance therapies
Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
Managing Evaluataion
The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
Opioid Overdose Deaths in the City and County of San Francisco
| Highly cited | No |
|---|